Identification of a genetic deletion in the SMN1 gene in the majority of 5q SMA patients and its resulting decrease in SMN protein [27] provided a rationale for aiming to restore SMN protein levels by manipulating the SMN2 paralogue. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.